Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

Overview

The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single
  • Study Primary Completion Date: December 2006

Interventions

  • Drug: Tobradex (Antibiotic steroid combination)

Clinical Trial Outcome Measures

Primary Measures

  • Anterior chamber inflammation

Secondary Measures

  • Aqueous cells and flare
  • ocular pain
  • physician’s impression of infection
  • frequency of treatment failures

Participating in This Clinical Trial

Inclusion Criteria

  • Patients scheduled for cataract extraction

Exclusion Criteria

  • Under 18 years

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Alcon Research

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.